Premium
Clinical Trial of Ferastral® in Iron‐deficient, Non‐pregnant Patients in Ibadan, Nigeria
Author(s) -
Esan G. J. F.,
Oluboyede O. A.,
Salako L. A.,
Akande E. O.
Publication year - 1977
Publication title -
scandinavian journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0036-553X
DOI - 10.1111/j.1600-0609.1977.tb01261.x
Subject(s) - medicine , iron deficiency , lesion , intravenous iron , intramuscular injection , surgery , gastroenterology , anemia
Fifteen patients with proven iron‐deficiency anaemia treated with intramuscular injections of Ferastral®, iron‐poly (sorbitol‐gluconic acid) complex, have been studied. Fourteen showed a satisfactory rise in haematocrit. No local or systemic complications were observed. One patient with iron‐deficiency anaemia due to a bleeding malignant lesion did not achieve a satisfactory haematocrit level although the bone marrow showed iron repletion following the injection. It is concluded that Ferastral is an effective drug in the treatment of iron‐deficiency anaemia.